Researchers testing new cancer vaccine
NEW ZEALAND– Melanoma patients in New Zealand are testing cutting edge therapy involving a possible vaccine.
Organizers say 50 patients fighting cancer are about to take part in a clinical trial which is testing a new vaccine therapy.
Researchers say initial tests show positive results by reducing the size of aggressive tumors.
The vaccine uses a synthetic version of a bacteria found in the common marine sponge, which may attack cancer cells.